Back to BlackRock, Inc.

LXEO
6 quarters

Position history for BlackRock, Inc.'s holdings in LEXEO THERAPEUTICS INC

BlackRock, Inc. holds 5.1M shares of LXEO (LEXEO THERAPEUTICS INC), worth $29.3M as of 2026-Q1. The position was increased (+4.1% shares). LXEO represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$29.3M

Current Shares

5.1M

Total Value Change

+$17.3M

Total Shares Change

+3.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5.1M
+4.1%
$29.3M0.0%$7.07
30
2025-Q4
Increased
4.9M
+126.0%
$48.7M0.0%$9.74
47
2025-Q3
Increased
2.2M
+18.8%
$14.4M0.0%$6.66
33
2025-Q2
Decreased
1.8M
-0.8%
$7.3M0.0%$4.12
0
2025-Q1
Increased
1.8M
+1.1%
$6.4M0.0%$4.10
27
2024-Q4
New
1.8M
-
$12M0.0%$6.54
39

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used